Shanghai Fosun Pharmaceutical (Group) Co Ltd

02196

Company Profile

  • Business description

    Shanghai Fosun Pharmaceutical (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceutical products and medical equipment, the import and export of medical equipment, and the provision of related and other consulting services and investment management. Its business segments are Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. It generates the majority of its revenue from the Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities. Its geographic areas are the Chinese mainland, Regions outside the Chinese mainland, and other countries.

  • Contact

    No. 1289 Yishan Road
    Building A, Fosun Technology Park
    Shanghai200233
    CHN

    T: +86 2133987000

    https://www.fosunpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    39,309

Stocks News & Analysis

video

Do you qualify as 'rich'?

Morningstar's Sim Mody speaks with Mark LaMonica about the varying definitions of rich. 
stocks

Solid sales from ASX healthcare leader

Solid device sales with shares moderately undervalued.
stocks

Megatrend Investing: ASX players to capitalise on the clean energy transition

Find out how you can benefit from global megatrends.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,683.4050.000.58%
CAC 407,875.7130.69-0.39%
DAX 4021,413.8691.84-0.43%
Dow JONES (US)44,556.04134.130.30%
FTSE 1008,566.554.22-0.05%
HKSE20,597.09192.87-0.93%
NASDAQ19,654.02262.061.35%
Nikkei 22538,831.4833.110.09%
NZX 50 Index12,844.5960.45-0.47%
S&P 5006,037.8843.310.72%
S&P/ASX 2008,416.9042.900.51%
SSE Composite Index3,229.4921.11-0.65%

Market Movers